BioCote | Anti-Microbial Protection � contourcasings.co.uk DeliverySecuritycontactbasket
+44 (0) 1952 290 498 / sales@contourcasings.co.uk
Home
Trionic LST Radiators
Rotarad Valve Kit
Radiator Guards
Aluminium Wall Capping
Column Casings
Fascias & Soffits
Floor Ducting
Manifold Guards
Pipe Boxing
BioCote
BioCote QC Test Archive
Case Studies
Project Data Sheets
Services
Technical Data
International
News
About us
Vacancies
Site map
Contact us

Contour Develop Scale Conversion Guide
Contour Column Casings Now Widely Specified
Save hundreds, Per Radiator, Per Year
Contour Launches New LST Radiator Brochure
Contour Launch Wall Coping Ranges

Why not sign up for all the latest news?

 
 
 
 

 

BioCote Anti-Microbial Protection

 

Contour Casings are the only company to incorporate BioCote anti-microbial protection into our radiator guards. This unique, patented additive to our powder coating provides an effective, safe and long lasting solution to combating a wide range of dangerous bacteria, including MRSA and E.coli.

The anti-microbial efficacy of BioCote products has been tested against a wide range of gram positive and gram negative bacteria as well as fungi. BioCote has been shown to inhibit the growth of these organisms, thus forming an effective part of good hygienic practice.

Download a copy of the BioCote datasheet or BioCote silver ion diagram for detailed information, simply click here...

Hospital Associated Infections

Studies have shown that at any one time, approximately 9% of hospital patients are suffering from a hospital acquired infection. This is unpleasant for the patient, increases their length of stay, and can lead to serious complication or death. The House of Commons public accounts committee says up to 5,000 patients die from a hospital-acquired infection every year, costing the NHS £1 billion.

Patients contracting a HAI spend an average of 2.9 times longer in hospital, with over 300, 000 HAI’s each year in England.

Hospital Trust expenditure on cleaning wards in 2004 exceeded £522 Million.

Research on the economic impact of HAI’s concluded that the cost of introducing preventative measures is less than treating infections. Around 15-30% could be prevented by better application of best practice, releasing resources of £150 – 300 million for alternative NHS use.

Proven Protection

The active agents in BioCote have been used extensively in Hospitals as excellent anti-microbials with low toxicity against non-target organisms. They do not function in the same way as antibiotics and there is no evidence to date to demonstrate that bacteria have become resistant to BioCote as they have to some antibiotics.

BioCote is tested to be effective against the following bacterium:

  • Staphylococcus Aureus (including MRSA)
  • Escherichia Coli (E-Coli)
  • Listeria Monocytogenes
  • Streptococcus faecalis
  • Salmonella enteritides

Life Time Protection

Products treated with BioCote have been tested for the simulated life of the product / material with no significant reduction in the anti-microbial performance noted, therefore demonstrating the anti-microbial efficacy for the life of the product / material.

For more information on BioCote, visit the website at www.biocote.com


   

CHAS Copyright 2003